Telswit‑40 Tablets consist of Telmisartan I.P. 40 mg, a long-acting angiotensin II receptor blocker (ARB). It effectively lowers systemic blood pressure by inhibiting angiotensin II–induced vasoconstriction and sodium retention. Telmisartan’s extended half-life supports once-daily dosing and provides sustained therapeutic coverage.
🔹 Benefits:
-
Consistent blood pressure control without peak-trough fluctuations
-
Protective effects on heart and kidneys, especially in diabetic patients
-
Good tolerability and metabolic neutrality
🔹 Indications:
-
Essential hypertension, alone or add-on therapy
-
Prevention of cardiovascular events in hypertensive patients
🔹 Dosage:
One tablet daily, with or without food. Dose adjustment may be required based on response.
🔹 Precautions:
-
Monitor renal function and electrolytes
-
Avoid in pregnancy, lactation, or bilateral renal artery stenosis
-
Side effects may include dizziness, fatigue, or mild gastrointestinal symptoms
🔹 Storage:
Store in a cool, dry place below 25 °C and keep out of reach of children.
Telswit‑40 provides a reliable, long-acting ARB to help keep blood pressure under control and lower cardiovascular risk.
